Semaglutide is a synthetic GLP-1 receptor agonist for metabolic and endocrine research. It enables investigation of glucose regulation, appetite signaling,
SS-31 (Elamipretide) is a mitochondria-targeted peptide (10mg,30mg,50mg) studied for protecting mitochondrial function. Acting as an antioxidant, it reduces reactive oxygen